ISSN: 2638-5945
Abdulghani A Naeem1, Saud A Abdulsamad1, Asmaa Al Bayati1, Jiachen Zhang1, Mohammed I Malki2, Hongwen Ma3, and Youqiang Ke1*
Received: February 11, 2022 Published: February 25, 2022
Corresponding author: Youqiang Ke, Professor, Department of Molecular & Clinical Cancer Medicine, Liverpool University, L69 3GA, United Kingdom
DOI: 10.32474/OAJOM.2022.05.000208
When it comes to studying biological processes, cell lines are typically utilized in lieu of original cell samples. Like in the studies for other cancer types, researchers in prostate cancer can be constrained in their ability to discover new treatments because of a lack of cell lines to investigate pre-clinical status. There are various forms of prostate cancer cell lines that are reviewed in this work. A cautionary note is in need since cell lines may not always correctly mimic the original cells. Cancerous cells are immortal and using cell lines produced from cancer cells as a model to better understand cancer and to develop novel therapies are common in research. Apart from the prostate cancer cells, we also reviewed two cell lines PNT2 and RWPE-1 which were established from non-neoplastic male prostatic epithelial cells.
Cancers are known for their ability to prolong life indefinitely
[1,2]. However, it remains a mystery how mortal somatic cells
become the source of immortal malignancies. Cancerous cells are
immortal, despite the fact that healthy somatic cells may develop
into organs as well as creatures that include much more cells than
lethal tumors [3-11]. By exceeding the Hayflick threshold, which
is approximately 50 cycles in vitro, immortality is established
operationally. Telomerase stimulation is now the most widely
accepted explanation of immortality [4-6]. Cancers are supposed to
gain immortality via the stimulation of telomerase, which is a gene
that is normally shut off throughout development in somatic cells.
To put it another way, cells that have maintained their telomeres by
the acts of telomerase process are considered to be immortalized.
All individual tumors seem to be governed by the process of cell
immortalization.
It is these cells that serve as a starting point for tumor
development and are known as the cancer cells of origin. Unlike
cancer stem cells, which constitute the cellular subfractions capable
of regenerating tumors, these cells are classified in a different way.
It’s been a major focus of cancer research to identify the cells that
give rise to the disease. Since there is so much interest in testing
the concept that tumors are caused by various cell types, this has
resulted in a lot of research being done in this area. This knowledge
will aid in the early detection and precise prognosis of cancer,
as well as in the development of new preventative treatments
for people at high risk. Based on the histological appearance of
malignancies, it was formerly considered that they had a cellular
origin. We now know, based on our existing understanding, that
tumor specimens may be deceiving when random as well as static
observations are made. A direct genetic method should be used to
test any hypotheses. Tumors may have gene expression patterns
that are more like those of their own cells’ ancestors than those of
other cell types within the same tissue, which is a similar but much
more elegant concept. The basal-like breast cancer may originate
from luminal epithelial progenitors in the mammary gland luminal
epithelium. Gene expression patterns may be used to classify brain
tumors with similar histological characteristics into separate
groups that represent the cellular genesis of the tumors. Molecular
profiles don’t always line up with tumor pathology, according
to these findings. It is still necessary to do more direct genetic
research in order to verify the findings drawn from these sorts of
studies. Cell lines having diverse lineage features from human or
mouse tissues may be established, transformed, and then analyzed to see whether the resultant tumors have a distinctive pathological
appearance. Using these cell lines, Ince et al. were able to generate
mammary gland epithelial cells with a luminal and a myoepithelial
phenotype. In the presence of the identical set of oncogenes, the two
kinds of cells differentiated into tumors with unique phenotypic
characteristics and propensity for malignancy.
When a multicellular organism’s cells are mutated, they
may continue to divide forever despite the fact that they would
ordinarily stop proliferating at a certain point. This is known as an
immortalized cell line. Because of this, the cells may be cultivated
in vitro for lengthy periods of time. In a laboratory, cell lines are
the simplest way to grow viruses. But primary cells taken from a
live animal or person are the sole option for viral culture in the
absence of cell lines that are sensitive to virus infection. Cells
derived from in vitro altered cell lines or malignant cells may be
cultivated in monolayer or suspended form, making them infinite
cell lines [7]. There’s a 12- to 14-hour growth period for these
cells; they’re capable of being grown forever. When doing scientific
studies, it’s usual to employ human cell lines. There has been
a long history in which cell lines have served as the backbone of
research into the mechanisms involved, the discovery of new
drugs, and the application of results to human illness. Human cell
lines are commonly used in the majority of labs [8]. Several were
formed generations earlier and dispersed around the scientific
community. A prevalent belief is that human cell lines produced
in one laboratory are identical to those in another. Not at all! The
molecular and cellular phenotype may change as a consequence of
changes in the number of passages or the environment in which
the cells are grown. A new Endocrine Society editorial guideline
mandates that all cell lines employed and reported in freshly
submitted and updated publications be authenticated in order
to ensure uniformity. Comparability and reproducibility among
researchers are made possible by the disclosure of information
including where and then when the cells were collected, if as well
as how they were examined and verified, and when the last test
was performed. With a lifetime prevalence of one in six, men in
the United States have the second most prevalent cause of cancerrelated
death from cancer (9-10). There are far more cell lines that
could also tell us about the biological condition of the prostate and
can be utilized to study the development of prostate cancer. This
means that new prostate cell lines must be developed immediately
to mimic human tissue samples in terms of the diverse phenotypes
seen. Using tissue recombination in immunodeficient mice models
to study the functional modification of real prostatic tissues is
a significant tool [11]. As a result, most current research lacks a
thorough knowledge of the pathways that lead to prostate cancer.
The human cell line PNT2 came from the prostate gland
tissue of a dead 33-year-old man. A plasmid harboring a Simian
virus genome with a faulty origin of replication (SV40 ori-) was
employed to immortalize the cell line [12]. The Simian virus is
routinely employed to memorialize mammalian epithelial cells.
PNT2 cells have the SV40 genome and express big T protein. A welldifferentiated
shape and the expression of cytokeratin distinguish
these cells from luminal cells of the prostate gland [13]. PNT2
cells are connected cell lines which develop with an epithelial
appearance. PNT2 produces cytokeratin (CK), member of the
keratin family. The keratin family are crucial in maintaining the
architecture of epithelial cells. CK8 and CK18 are joined together
as partners and operate as plasminogen receptors [13]. CK19 is
produced in the periderm and is a characteristic of differentiated
luminal cells.
PNT2 cells are often utilized in medical research, for instance
by Baker et al in 2008, who employed secondary ion mass
spectrometry to discriminate between prostate cancer cells and
non-malignant cells [14]. They have also been employed by Faria,
et al. in 2008 as part of an inquiry into the assessment of the elastic
characteristics of prostate cancer utilizing Atomic Force Microscopy
(AFM). Another example of PNT2’s use is by Smith et al in 1998,
when sodium channel expression was demonstrated to boost the
intrusiveness of rat and human prostate cancer cells. The medium
that PNT2 should be cultivated in is RPMI 1640 + 2mM Glutamine
+ 6-10 percent Foetal Bovine Serum (FBS) at 37°C + 5 percent CO2
[15]. The cells should be planted at roughly 2-4 x 104 cells/cm2 and
should be passaged when the subculture is between 70-80 percent
confluent using 0.25 percent trypsin or trypsin/EDTA. These cells
should be handled under laboratory containment level 2 [16].
Research into the etiology of prostate cancer and benign tumors of the prostate in the United States has been hindered due to the difficulties of acquiring fresh human tissue and the dearth of well-characterized cell lines that display development and differentiation features of normal prostatic epithelium. Male prostatic epithelial cells from a non-neoplastic source were immortalized with human papillomavirus to create the RWPE-1 cell line [17]. For the RWPE-2 cell line, derived from RWPE-1, was transformed using v-Ki-ras. Both RWPE-1 and RWPE-2 cells were shown to contain cytokeratins 8 and 18, which are associated with luminal prostatic epithelial cells, but they mostly co-express basal cell cytokeratins [17]. In reaction to the synthetic androgen mibolerone, these cell lines display growth stimulation, PSA and androgen receptor (AR) expression, establishing their prostatic epithelial origin. When exposed to EGF and bFGF, the RWPE-2 cells are more sensitive to stimulation, but when exposed to TGF-beta they are less receptive. Injection of RWPE-1 cells into naked mice, with or without Matrigel, does not cause the cells to proliferate in agar or create tumors [19-34]. Nude mice develop tumors from RWPE-2 cells, which grow as colonies on agar. RWPE-1 cells do not invade in the in vitro invasion experiment, while RWPE-2 cells do [34]. Both cell lines showed varying levels of nuclear p53 and Rb protein expression. Cell culture models of RWPE-1 and RWPE- 2 cells may be used to study the control of prostate growth and carcinogenesis, respectively [34].
In terms of male cancer deaths, the top cause is prostate cancer [18]. Androgen receptor (AR-H874Y) in CWR-R1 cells is functional and activated at low doses of testosterone or dihydrotestosterone (DHT), with a single mutation (AR-H874Y) (DHT) AR-FL, AR-V7, and PSA mRNA and protein are expressed in cells. In a monolayer, cells may be propagated for more than 50 passages with low concentrations of DHT, cell line is an epithelial-stromal fibroblast co-culture. It is the development of prostate cancer, a disease of the male reproductive system, which affects the prostate. The AR is a focus for many anti-cancer research investigations because it promotes prostate cancer cells to thrive [19]. Normal prostate growth and maintenance depends on the AR, as does prostate cancer survival and advancement. These anti-androgen therapies, which are now used in the management of advanced disease prostate cancer, bind to the AR binding region and reduce or block androgen production [20]. The initial response to androgen deprivation treatment is positive, but most patients ultimately revert to a more severe, castration-resistant prostate cancer (CRPC), which is caused by the ongoing transactivation of AR. Developed from the castration-resistant or recurrent CWR-R1 prostate cancer cell line, in the beginning, the CWR-R1 cell line was obtained from the recurrent human xenograft tumors from murine 140-160 days after sterilization and expresses AR full length (AR-FL), AR-V7, and the mRNA and protein for prostate-specific antigen. When castration fails to eradicate prostate cancer, the CWR-1Ca cell line may be used to generate fibroblast-free cell lines that are resistant to the treatment [19]. Multiple rounds of brief trypsinization, cloning as well as pooling single-cell colonies were used to remove fibroblasts from the original parental CWR-R1 cells [19]. When androgen is used to stimulate cell proliferation, the CWR-1ca cells express the androgen receptor AR-FL as well as its splice variant AR-V7 [20].
Due to a lack of cell lines to investigate pre-clinical prostate
cancer, researchers were constrained in their ability to discover
new treatments. previously, there was a lack of cell lines that
adequately represent the clinical development of prostate cancer
in humans [24]. Horoszewicz, et al. first described the formation
of subcutaneous tumors in intact male athymic nude mice by using
LNCaP, a cell line obtained from a metastatic lymph node lesion of
human prostate cancer that is AR positive and androgen-sensitive
[24]. The initial source of the LNCaP cell line was a metastatic
prostate cancer patient’s lymph node. LNCaP has been used to
generate a plethora of cell lines for research into the development
of prostate cancer [25]. Subcutaneous injections of LNCaP and its
derivatives into male athymic nude mice do not cause metastasis.
JHU-LNCaP-SM cells developed swiftly into tumors in intact male
athymic nude mice with a 100% (13/13) tumor take rate. Five
days after inoculation, tumors were visible, but tumor-free LNCaPinfected
mice failed to develop tumors (0/15) over the same
timeframe. Mice with developed tumors larger than 300 mm3 were
surgically castrated to examine the androgen independence of JHULNCaP-
SM tumor xenografts. A lack of tumor volume variation was
seen in both groups, which suggests that treatment with androgen
does not affect the rate of exponential development [25].
When it comes to men’s malignancies, prostate cancer is the
most prevalent and the second most common cause of cancerrelated
fatalities. Patients with advanced prostate cancer may
benefit greatly from androgen restriction treatment, since
androgen signaling is critical to prostate cancer development
and antiapoptotic capabilities [26]. But even after an initial
response to androgen restriction treatment, castration-resistant
prostate cancer (CRPC) develops, leading to its recurrence and/
or progression. Patients with advanced prostate cancer have been
given novel AR-targeted medicines, such as enzalutamide (ENZ), as
well as an anti-cancer chemotherapeutic agent, called Cabazitaxel
[24,25]. However, these medications have been shown to have poor
treatment effectiveness. Although the majority of CRPC tumors
display AR-dependent development by activating AR mutations,
amplification, or splice variants, up to 10-20 percent of CRPC
cancers remove their AR reliance to avoid AR-targeted treatment
are also present. AR-positive adenocarcinomas may become ARnegative
small cell neuroendocrine prostate carcinomas, a symptom
of this process (NEPCs). D growth, high-throughput screening, and
development of xenograft tumors for in vivo testing are essential
tools for discovering the determinants of therapy response and
resistance [26]. However, contemporary cancer cell lines have a
few drawbacks that must be considered. In vitro culture-grown
tumor cell lines are used to create new cell lines based on already
existing ones. Cancer cell lines produced by this method are not
representative of the wide range of human malignancies [26]. There
is little variability among PCa cell lines generated in monolayer
cultures compared to those obtained from patient tumors. The NCI-
60 cell line and its 60 human panel have been withdrawn by the
National Cancer Institute of the United States.
22Rv-1 cell is a human prostate cancer epithelial cell line that was generated from the xenograft of a CWR22 xenograft that was castrated and relapsed in mice before being serially reproduced in mice [27]. Prostate specific antigen (PSA) is expressed in the cell line. By Western blot examination, dihydroxytestosterone very slightly increases growth, although lysates are immunoreactive with antibodies to the androgen receptor [28]. Transforming growth factor beta-1 does not limit growth but rather stimulates it (TGF beta- 1). Human retrovirus XMRV has recently been shown to be highly titrated in 22Rv1 prostate cancer cells (xenotropic murine leukemia virus-related virus). Researchers often employ the 22Rv1 xenograft mouse cell line and in vitro cell culture tests to investigate the carcinogenesis of prostate cancer. XMRV, a gammaretrovirus, has recently been shown to be integrated into the genome of this cell line. When compared to CWR22, the xenograft cell lines 22Rv1 and CWR-R1, both of which include retroviruses in their supernatant, have been shown to be infected with gammaretrovirus [30]. XMRV has been shown to infect human cells in vitro, despite the fact that it was most likely created by recombination processes in cell culture, and 22Rv1 and CWR-R1 cells are now deemed biosafety reagents [28]. When compared to the original cell line, 22Rv1 cells with reduced retroviral transcription exhibit lower tumor angiogenesis and enhanced necrosis of the main tumor formed by xenografted cells in SCI mice. When XMRV transcripts are present, osteopontin (OPN), CXCL14, IL13, and TIMP2 production in 22Rv1 cells rises considerably. Cell invasion and differentiation studies carried out in vitro provide further evidence to back up these findings [28]. As a result of our findings, we believe that 22Rv1 features like as migration, invasion, and tumor angiogenesis are at least partly influenced by the presence of XMRV transcripts. Prostate cancer cell lines containing xenotropic gammaretroviruses, such as 22Rv1 and other cell lines evaluated for viral sequences, should be carefully regulated.
Human prostate cancer cell line DU145 is also known as DU-
145 [31]. There are three primary prostate cancer cell lines that
are employed in therapeutic research: DU145, PC3, and LNCaP.
Cell lines DU145, PC-3 and LNCaP have all been generated from
metastatic prostate cancer lesions in the brain, bone and lymph
node tissues, respectively [25]. Different tumor microenvironments
and origins of various cell lines have resulted in diverse properties
of these cells [32]. Prostate-specific antigen is expressed in DU145
cells, which are unresponsive to androgen. These are typical of
prostate cancer lesions that are difficult to cure.
A decrease in CDK2 and CDK4 activity, as well as in cyclin
A and cyclin D1 levels, are all associated with G1 phase arrest in
DU145 prostate cancer cells when IAA is added [31]. EGF Receptor
overexpression is common in advanced prostate cancer. Cetuximab
therapy has been shown to improve radiation sensitivity in the
prostate cancer cell line DU145 in vitro; however, there are not
enough clinical data to back this up.
Combining radiation and cetuximab therapy reduces cell
proliferation in the DU 145 prostate cancer cell line, whereas
cetuximab treatment alone had little effect. In a proliferation
experiment, DU145 cells seemed to be more resistant to radiation
and less responsive to cetuximab. Human prostatic cancer cell
line DU145 (also known as DU-145) The standard prostate cancer
cell lines utilized in therapeutic research include DU145, PC3, and
LNCaP. It was shown that DU145 cells had a much greater GSH
concentration and GSH/GSSG ratio compared to PC3 cells. DU145
cells also showed substantial increases in the basal and stimulated
levels of Nrf2 and the genes it depends on.
Human prostate cancer bone metastases were used to isolate the PC3 cell line, which had a low degree of differentiation [34]. In spite of its modest metastatic potential, it lacks endogenous androgen receptors, making it a prostate cancer cell that is androgen-independent [34]. Research into androgen-resistant prostate cancer relies on the PC3 cell line. In the study of prostate cancer, PC3 (PC-3) is a human prostate cancer cell line. Biochemical alterations in advanced prostate cancer cells and their response to chemotherapeutic drugs may be studied using PC3 cells. Viral infection of immune-responsive mammalian cells is also studied using PC3 cells. In 1979, a 62-year-old Caucasian man was diagnosed with grade IV prostate cancer, and the PC3 cell line was created from his bone metastases. Androgens and glucocorticoids have little effect on these cells but data show that they are impacted by epidermal growth factors. Subcutaneous tumor xenografts of PC3 cells in mice may be employed for research into the tumor environment and therapeutic medication functionality [34]. The metastatic potential of PC3 cells is more than that of DU145 cells, which is moderate, and greater than that of LNCaP cells, which is low. The protein expression of PC3, LNCaP, and other cells has indicated that PC3 is typical of small cell neo endocrine cancer (25). Testosterone-5-alpha reductase and acidic phosphatase activity in PC3 cells is minimal, and they exhibit no PSA (prostatespecific antigen). Furthermore, a karyotypic examination of PC3 revealed that the cells had 62 chromosomes, making them almost triploid. The absence of a Y chromosome was revealed by Q-band analysis. PC3 cells exhibit hallmarks of a weakly differentiated adenocarcinoma, according to electron microscopy findings. There are many microvilli, junctional complexes, aberrant nuclei and nucleoli, abnormal mitochondria, annulate lamellas, and lipoidal structures in these cells [35,36].
There is still a need for a reliable, early detection method for
prostate cancer, despite several molecular tests being developed in
recent years and some receiving FDA approval. As a result, the hunt
for new, more specific, as well as cost-effective biomarkers that may
enhance early detection of prostate cancer and more accurately
predict its clinical course is an important research objective. It is
possible for cancer cells to alter several homeostatic processes in the
body, resulting in changes in the synthesis, usage, and levels of many
metabolites. Metabolomics is a potent analytical tool in oncology
that may identify new biomarkers and therapeutic targets. Noninvasive
samples may be studied using a metabolomic technique to
find biochemical markers and, as a result, discrepancies between
cancer as well as healthy metabolic phenotypes. Metabolomics may
be used to intervene early since metabolic changes are thought
to precede the growth of neoplastic cells. Biofluids (e.g., urine
and serum/plasma), tissues, and cell lines are the most prevalent
matrices employed in prostate cancer metabolomics investigations.
Biofluids and tissues, in particular, might have metabolic profiles
that are influenced by variables other than cancer cell metabolism,
such as age, food, medicines, or chronobiological fluctuations; this
must be considered when working with these types of matrices
in order to produce accurate findings. In contrast, studies using
cultured cell lines offer significant benefits over the use of urine or
plasma, overcoming these drawbacks. There are several benefits
to the use of pre-clinical investigations using cell lines, such as the ability to exclude several significant confounding variables, such as
age and nutrition. Because cell lines have a fixed state, they may be
used to analyze a specific metabolic condition.
Consequently, we think that cell lines are the appropriate
matrix to generate hypotheses about cellular processes and to
uncover metabolic abnormalities that are not visible in research
utilizing animal models or human patients because of their
biological complexity. There are a few drawbacks to this in vitro
model, however, such as a lack of cell–cell interactions between
cultured cells and the tumor microenvironment, which is critical
for the metabolic changes that occur during tumor progression.
Because of this, the results of in vitro research need to be confirmed
and validated in biofluids from patients with prostate cancer.
Immortal cell lines are widely utilized in research in lieu of primary
cells. They provide various benefits, such as they are cost efficient,
simple to utilize, give an endless supply of material and circumvent
ethical considerations related with the use of animal and human
tissue. Cell lines can give a pure population of cells, which is useful
as it delivers a consistent sample and repeatable findings. There are
several papers employing cell lines as well as the American Type
Culture Collection (ATCC) Cell Biology Collection which includes
of cell lines [37-41] Cell line popularity may be judged from the
numerous publications using cell lines. However, while being a
strong tool, one must be cautious when employing cell lines in lieu
of source cells. Cell lines should express and preserve functional
properties as near to primary cells as feasible. This may especially
be difficult to ascertain since frequently the roles of the main cells
are not totally known. Since cell lines are genetically altered this
may affect their phenotypic, natural functions and their reactivity to
stimuli. Serial passage of cell lines may further produce genotypic
and phenotypic diversity over a long period of time and genetic
drift can also cause variability in cultures at a single point in time.
Therefore, cell lines may not effectively mimic primary cells and
may produce different outcomes.
It is clear that cell lines are an excellent alternative to primary cells in many ways. To be clear, cell lines don’t exactly replicate primary cells. Therefore, careful consideration must be given to the design of investigations in order to ensure that results obtained by using cell line are solid. Primary cells should be used to duplicate important research. As a final point, it’s important to acknowledge that studying primary cells and cell lines in an in vitro setting deprives them of important interactions with other cell types that might be vital to testing a theory. There are several studies showing that Sertoli cells interact with different cell types in the surrounding environment, which makes them especially sensitive to isolation or enrichment.
Authors AAN and SAA, contributed equally to this work, are supported by a Ph.D scholarship from king Saud Bin Abdulaziz University for Health Sciences, College of Science and Health Professions, Jeddah, Saudi Arabia.
Bio chemistry
University of Texas Medical Branch, USADepartment of Criminal Justice
Liberty University, USADepartment of Psychiatry
University of Kentucky, USADepartment of Medicine
Gally International Biomedical Research & Consulting LLC, USADepartment of Urbanisation and Agricultural
Montreal university, USAOral & Maxillofacial Pathology
New York University, USAGastroenterology and Hepatology
University of Alabama, UKDepartment of Medicine
Universities of Bradford, UKOncology
Circulogene Theranostics, EnglandRadiation Chemistry
National University of Mexico, USAAnalytical Chemistry
Wentworth Institute of Technology, USAMinimally Invasive Surgery
Mercer University school of Medicine, USAPediatric Dentistry
University of Athens , GreeceThe annual scholar awards from Lupine Publishers honor a selected number Read More...